| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 13 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 3 | PREDNISOLONE | 11 |
| 4 | PREDNISOLONE ORAL | 11 |
| 5 | PREDNISOLONE ORAL SOLUTION | 11 |
| 6 | ETOPOSIDE | 7 |
| 7 | MERCAPTOPURINE | 7 |
| 8 | OLANZAPINE | 6 |
| 9 | AZATHIOPRINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUNISAL | 1 | 0.0012 |
| 1 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 2 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 3 | FLURBIPROFEN | 1 | 0.0007 |
| 4 | NIZATIDINE | 1 | 0.0007 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 6 | DROPERIDOL | 1 | 0.0006 |
| 7 | DACTINOMYCIN | 1 | 0.0005 |
| 8 | MENOTROPINS | 1 | 0.0005 |
| 9 | SULINDAC | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 18 |
| 1 | Alkylating Drug [EPC] | 15 |
| 2 | Atypical Antipsychotic [EPC] | 7 |
| 3 | Topoisomerase Inhibitor [EPC] | 7 |
| 4 | Anti-epileptic Agent [EPC] | 6 |
| 5 | Mood Stabilizer [EPC] | 6 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 7 | Platinum-based Drug [EPC] | 5 |
| 8 | Purine Antimetabolite [EPC] | 5 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 1 | 0.0005 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 15 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Progesterone [EPC] | 1 | 0.0000 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |